Name: Latest research reports of Solara Active Pharma Sciences Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Solara Active Pharma Sciences Ltd.
Rating: 5
Author: Axis Direct

Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540 | ISIN: INE624Z01016 | Industry: Pharmaceuticals
| Expensive Rocket

714.8500 -10.55 (-1.45%)

NSE Oct 01, 2026 15:31 PM

69.40% Gain from 52W Low

Volume: 244.8K

Solara Active Pharma Sciences Ltd.

04 Feb 2021, 12:00AM

714.85

-1.45%

Result Update:Solara Active

Buy: Solara Active Pharma Scien...

Target

Axis Direct

Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.

Promoters pledged 5.54% of shares in last quarter. Total pledge stands at 37.11% of promoter holdings